Safety, Tolerability and Pharmacokinetics of FTP-198 in Healthy Australian Volunteers

NCT04526496 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

75

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: FTP-198, single dose
DRUG: Placebo, single dose
DRUG: FTP-198, multiple doses
DRUG: Placebo, multiple doses

Sponsor

Sichuan Haisco Pharmaceutical Group Co., Ltd